Resmed (RMD) Other Non-Current Assets (2010 - 2026)
Resmed's (RMD) quarterly Other Non-Current Assets came in at $210.7 million in Q1 2026, up 20.67% YoY from $174.6 million in Q1 2025, and up 8.69% on a QoQ basis from $193.9 million in Q4 2025.
Resmed (RMD) Other Non-Current Assets (2010 - 2026) Analysis & Trends
Resmed (RMD) has 17 years of Other Non-Current Assets data on file, last reported at $210.7 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 20.67% year-over-year to $210.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $210.7 million (up 20.67% YoY) and the FY2025 annual result came in at $185.8 million, down 34.56% from the prior year.
- Other Non-Current Assets advanced to $210.7 million in Q1 2026, from $193.9 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $284.0 million in Q2 2024 to a low of $169.4 million in Q1 2022.
- A 5-year average of $225.0 million and a median of $210.7 million in 2026 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets soared 12772.93% — and 2025, when it tumbled 37.03%.
- Tracing RMD's Other Non-Current Assets over 5 years: stood at $260.2 million in 2022, then rose by 6.02% to $275.8 million in 2023, then tumbled by 34.31% to $181.2 million in 2024, then grew by 7.01% to $193.9 million in 2025, then increased by 8.69% to $210.7 million in 2026.
- The last three Other Non-Current Assets figures came in at $210.7 million (Q1 2026), $193.9 million (Q4 2025), and $189.8 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Align Technology | 11.61 Bn | 10.51 Bn | 757.43 Mn | 452.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 457.39 Mn |
| Mar 31, 2026 | 210.73 Mn |
| Dec 31, 2025 | 193.88 Mn |
| Sep 30, 2025 | 189.84 Mn |
| Jun 30, 2025 | 185.84 Mn |
| Mar 31, 2025 | 174.63 Mn |
| Dec 31, 2024 | 181.18 Mn |
| Sep 30, 2024 | 278.85 Mn |
| Jun 30, 2024 | 284.00 Mn |
| Mar 31, 2024 | 277.33 Mn |
| Dec 31, 2023 | 275.82 Mn |
| Sep 30, 2023 | 265.11 Mn |
| Jun 30, 2023 | 262.45 Mn |
| Mar 31, 2023 | 270.87 Mn |
| Dec 31, 2022 | 260.16 Mn |
| Sep 30, 2022 | 173.43 Mn |
| Jun 30, 2022 | 171.75 Mn |
| Mar 31, 2022 | 169.40 Mn |
| Dec 31, 2021 | 2.02 Mn |
| Sep 30, 2021 | 162.99 Mn |